Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01874327 · ClinicalTrials.gov registry record · NA
Biomarkers of Developmental Trajectories and Treatment in Autism Spectrum Disorder (ASD)
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT01874327 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 110 participants.
The verdict
NCT01874327, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
The study will evaluate the efficacy of a novel intervention implemented in a classroom setting aimed at improving joint attention and joint engagement skills with infants who are at risk of developing an Autism Spectrum Disorder.
Interventions
- BEHAVIORAL Baby JASPER
- BEHAVIORAL Standard Baby Classroom
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2013-01 |
| Est. Completion | 2018-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01874327
The ClinicalTrials.gov registry entry for NCT01874327 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Baby JASPER is the first listed.
NCT01874327 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01874327 about?
NCT01874327 is a clinical study titled "Biomarkers of Developmental Trajectories and Treatment in Autism Spectrum Disorder (ASD)". The study will evaluate the efficacy of a novel intervention implemented in a classroom setting aimed at improving joint attention and joint engagement skills with infants who are at risk of developing an Autism Spectrum Disorder.
What is the current status of trial NCT01874327?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2013-01. Estimated completion is 2018-09.
What interventions are being tested in trial NCT01874327?
The interventions under investigation include: Baby JASPER (BEHAVIORAL), Standard Baby Classroom (BEHAVIORAL).
Who is sponsoring clinical trial NCT01874327?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.